Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Nervous system disorders – page 80

  • 1 397 clinical trials
  • 586 recruiting
  • 459 conditions
  • 29 countries

Conditions in this area

459 conditions with trials, the busiest first

Dementia Alzheimer's type87Multiple sclerosis59Parkinson's disease56Ischaemic stroke52Migraine48Myasthenia gravis44Glioblastoma41Amyotrophic lateral sclerosis31Duchenne muscular dystrophy28Neuroblastoma26Relapsing multiple sclerosis21Glioma20Relapsing-remitting multiple sclerosis20Narcolepsy19Partial seizures19Cognitive disorder18Epilepsy18Giant cell arteritis18Anaesthesia17Chronic inflammatory demyelinating polyradiculoneuropathy17Spinal muscular atrophy17Subarachnoid haemorrhage16Autism spectrum disorder15Insomnia15+435

Clinical trials in Nervous system disorders

1 397 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

1 397 clinical trials

Parkinson's disease

Not recruiting

Study on How Exenatide Affects Early Parkinson's Disease Progression in Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Exenatide
  • Sponsor:Region Stockholm – SLSO

Narcolepsy

Not recruiting

Study on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 2

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:ALKS 2680
  • Sponsor:Alkermes Inc.

Dementia Alzheimer's type

Not recruiting

Study of Remternetug for Patients with Early Alzheimer's Disease at Risk for Cognitive and Functional Decline

Investigational
Countries:SpainSpain
  • Participants:65+ years
  • Substances:LY3372993
  • Sponsor:Eli Lilly & Co.

Glioma

Not recruiting

Study on the Safety and Effectiveness of Sirolimus for Treating High-Grade Glioma in Children

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Sirolimus
  • Sponsor:Instytut Pomnik Centrum Zdrowia Dziecka

Multiple sclerosis

Not recruiting

Study on the Safety and Effectiveness of TolDec and Immunotherapy for Patients with Relapsing-Remitting Multiple Sclerosis

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Autologous tolerogenic dendritic cells
  • Sponsor:Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer

Neurotrophic keratopathy

Not recruiting

Study on the Safety and Effectiveness of Timbetasin Acetate Eye Drops for Patients with Neurotrophic Keratopathy

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Timbetasin Acetate
  • Sponsor:Regentree LLC

Neuropathy peripheral

Not recruiting

Study on the Effects of AT-007 for Patients Aged 16-55 with Sorbitol Dehydrogenase Deficiency

Investigational
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years
  • Substances:Govorestat
  • Sponsor:Applied Therapeutics Inc.

Duchenne muscular dystrophy

Not recruiting

Study on Metoprolol for Preventing Heart Disease in Boys with Duchenne Muscular Dystrophy Aged 8-17

Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Metoprolol Tartrate
  • Sponsor:Medical University Of Gdansk

Cluster headache

Not recruiting

Study on Ketamine and Magnesium Sulfate for Treating Chronic Cluster Headache in Patients Unresponsive to Standard Treatments

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:University Hospital Of Clermont-Ferrand

Myasthenia gravis

Not recruiting

Study on Rituximab for Patients with Generalized Myasthenia Gravis

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Huntington's disease

Not recruiting

Study on the Effects of Metformin on Cognitive Function in Patients with Huntington's Disease

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Hydrochloride
  • Sponsor:IIS La Fe

Subarachnoid haemorrhage+1

Not recruiting

Study on Urea for Treating Low Sodium Levels in Patients with Brain Hemorrhage

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Urea
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Substances studied in this area

The therapies tested most often in Nervous system disorders trials.

Sodium Chloride71 clinical trialsTemozolomide38 clinical trialsOcrelizumab33 clinical trialsRituximab27 clinical trialsCyclophosphamide24 clinical trialsParacetamol24 clinical trialsMethylprednisolone15 clinical trialsPrednisolone15 clinical trialsCarboplatin14 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.